Elsevier

Annals of Oncology

Volume 21, Issue 1, January 2010, Pages 187-189
Annals of Oncology

letters to the editor
Incorporating the antidiabetic drug metformin in HER2-positive breast cancer treated with neo-adjuvant chemotherapy and trastuzumab: an ongoing clinical–translational research experience at the Catalan Institute of Oncology

https://doi.org/10.1093/annonc/mdp494Get rights and content
Under an Elsevier user license
open archive

Cited by (0)